Page last updated: 2024-08-23

pirfenidone and fumarates

pirfenidone has been researched along with fumarates in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	2 (40.00)	2.80

Authors

Authors	Studies
Burton, JM; O'Connor, P	1
Declèves, AE; Sharma, K	1
Shah, SV	1
AlQudah, M; Czubryt, MP; Hale, TM	1
Bansal, AK; Bose, A; Chakraborty, S; Das, S; Ghosh, A; Kumari, N; Pandey, N; Parmar, PK; Roy, P; Roy, S	1

Reviews

4 review(s) available for pirfenidone and fumarates

Article	Year
Novel oral agents for multiple sclerosis. Current neurology and neuroscience reports, 2007, Volume: 7, Issue:3 Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cladribine; Clinical Trials as Topic; Dimethyl Fumarate; Fingolimod Hydrochloride; Fumarates; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Interferon beta-1b; Interferon-beta; Isoxazoles; Leflunomide; Minocycline; Multiple Sclerosis; Mycophenolic Acid; Propylene Glycols; Pyridones; Quinolones; Sphingosine	2007
New pharmacological treatments for improving renal outcomes in diabetes. Nature reviews. Nephrology, 2010, Volume: 6, Issue:6 Topics: Albuminuria; Amides; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Biomarkers; Clinical Trials as Topic; Diabetic Nephropathies; Disease Progression; Fumarates; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Protein Kinase C; Pyridones; Renin; Transforming Growth Factor beta	2010
Progress toward novel treatments for chronic kidney disease. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, 2010, Volume: 20, Issue:5 Suppl Topics: Amides; Anticoagulants; Antihypertensive Agents; Bicarbonates; Chronic Disease; Enzyme Inhibitors; Fumarates; Glycosaminoglycans; Humans; Indoles; Iron Chelating Agents; Kidney Diseases; Kidney Failure, Chronic; Maleimides; Pentoxifylline; Phosphodiesterase Inhibitors; Protein Kinase C; Pyridones; Renin; Renin-Angiotensin System	2010
Targeting the renin-angiotensin-aldosterone system in fibrosis. Matrix biology : journal of the International Society for Matrix Biology, 2020, Volume: 91-92 Topics: Amides; Angiotensins; Animals; Benzimidazoles; Biphenyl Compounds; Extracellular Matrix; Extracellular Matrix Proteins; Fibroblasts; Fibrosis; Fumarates; Gene Expression Regulation; Humans; Kidney; Liver; Molecular Targeted Therapy; Myocardium; Pyridones; Renin-Angiotensin System; Signal Transduction; Skin; Tetrazoles; Transforming Growth Factor beta	2020

Other Studies

1 other study(ies) available for pirfenidone and fumarates

Article	Year
Investigating the Role of the Reduced Solubility of the Pirfenidone-Fumaric Acid Cocrystal in Sustaining the Release Rate from Its Tablet Dosage Form by Conducting Comparative Bioavailability Study in Healthy Human Volunteers. Molecular pharmaceutics, 2022, 05-02, Volume: 19, Issue:5 Topics: Administration, Oral; Area Under Curve; Biological Availability; Cross-Over Studies; Delayed-Action Preparations; Fumarates; Healthy Volunteers; Humans; Pyridones; Solubility; Tablets; Therapeutic Equivalency	2022

Article

Year

Investigating the Role of the Reduced Solubility of the Pirfenidone-Fumaric Acid Cocrystal in Sustaining the Release Rate from Its Tablet Dosage Form by Conducting Comparative Bioavailability Study in Healthy Human Volunteers.

Molecular pharmaceutics, 2022, 05-02, Volume: 19, Issue:5

Topics: Administration, Oral; Area Under Curve; Biological Availability; Cross-Over Studies; Delayed-Action Preparations; Fumarates; Healthy Volunteers; Humans; Pyridones; Solubility; Tablets; Therapeutic Equivalency

2022